Advertisement
Screener

STREAMEX CORP. (STEX) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

1.4 / 5 stars · 17/59 Roast Me

STREAMEX CORP. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

STREAMEX CORP. (STEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 5.59 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-14

  • STREAMEX CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-06-30 was -2.96B shares.
  • STREAMEX CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 2.96B shares.
  • STREAMEX CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-09-30 was 0.00 shares.
  • STREAMEX CORP. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 37.75K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, GrantedShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed
2026-06-30-2.96B shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
5.59M shares
10-Q · filed 2026-08-14
2026-03-312.96B shares
10-Q · filed 2026-05-14
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
2.20M shares
10-Q · filed 2024-11-14
2024-06-302.20M shares
10-Q · filed 2024-08-14
2022-12-3137.75K shares
10-K · filed 2024-04-16
375.00K shares
10-K · filed 2023-03-31
2020-08-1150.00K shares
10-Q · filed 2020-11-05
2020-07-1450.00K shares
10-Q · filed 2020-11-05
2020-07-1382.72K shares
10-K · filed 2022-03-31
2020-03-30960.00K shares
10-K · filed 2022-03-31
2020-03-25338.00K shares
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B